Literature DB >> 30325846

Extracorporeal Membrane Oxygenation for Adults With Refractory Septic Shock.

Jordi Riera1, Eduard Argudo, Juan Carlos Ruiz-Rodríguez, Ricard Ferrer.   

Abstract

Because of a severe dysregulation of the host response to infection, septic shock may induce a profound imbalance between oxygen consumption and delivery, which in some cases may be refractory to conventional support measures. In this setting, extracorporeal membrane oxygenation (ECMO) may help to restore this ratio. Indeed, in neonates and children, this technique is already established as a valid salvage therapy. In spite of the rapid growth in the use of ECMO in recent years, the evidence of its benefits in adult patients is weak, particularly in cases of refractory septic shock. Nevertheless, several case series have reported good outcomes in selected cases with specific management. Here we explore the links between sepsis and ECMO, starting with the basic biology underlying the two entities. We then review the published literature on the use of extracorporeal support in adult patients with septic shock and finally conclude with a review of the key points of management that can optimize the results after this critical situation.

Entities:  

Mesh:

Year:  2019        PMID: 30325846     DOI: 10.1097/MAT.0000000000000905

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  3 in total

1.  Risk factors for refractory septic shock treated with VA ECMO.

Authors:  Lei Han; Yan Zhang; Yonghui Zhang; Wei Wu; Ping He
Journal:  Ann Transl Med       Date:  2019-09

2.  A 20-year experience with cryopreserved allografts as the valve replacement of choice in aortic root reconstruction for destructive endocarditis with abscess formation.

Authors:  Afram Yousif; Khaldoun Ali; Marcel Anssar; Wolfgang Harringer; Aschraf El-Essawi; René Brouwer
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-07-09

3.  Extracorporeal membrane oxygenation with continuous renal replacement therapy to treat metformin-associated lactic acidosis: A case report.

Authors:  Ting Chen; Chunyan Zhu; Bao Liu
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.